Lipigon Pharmaceuticals AB (FRA:9RP) Short Interest


What is Lipigon Pharmaceuticals AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:9RP vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Lipigon Pharmaceuticals AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lipigon Pharmaceuticals AB Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipigon Pharmaceuticals AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Lipigon Pharmaceuticals AB's Short Interest falls into.


Lipigon Pharmaceuticals AB Business Description

Address Tvistevagen 48 C, Umea, SWE, 90736
Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.